The long-acting β-adrenoceptor agonist, indacaterol, inhibits IgE-dependent responses of human lung mast cells

British Journal of Pharmacology

Volumn 158, Issue 1, 2009, Pages 267-276

  Scola, Anne Marie ^a   Loxham, Matthew ^a   Charlton, Steven J ^b   Peachell, Peter T ^a  

^a UNIVERSITY OF SHEFFIELD   (United Kingdom)

^b NOVARTIS INSTITUTES FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

2 adrenoceptors; Asthma; Bronchodilators; Histamine

Indexed keywords

BETA ADRENERGIC RECEPTOR; FORMOTEROL; HISTAMINE; IMMUNOGLOBULIN E; INDACATEROL; ISOPRENALINE; LONG ACTING DRUG; PEPTIDOLEUKOTRIENE; PROSTAGLANDIN D2; SALMETEROL;

ARTICLE; CONTROLLED STUDY; DRUG ACTIVITY; DRUG EFFICACY; DRUG POTENCY; HISTAMINE RELEASE; HUMAN; HUMAN CELL; IMMUNOGLOBULIN PRODUCTION; MAST CELL; PRIORITY JOURNAL; PROSTAGLANDIN SYNTHESIS;

ADRENERGIC BETA-AGONISTS; DOSE-RESPONSE RELATIONSHIP, DRUG; HISTAMINE RELEASE; HUMANS; IMMUNOGLOBULIN E; INDANS; LUNG; MAST CELLS; QUINOLONES; TIME FACTORS;

EID: 69249214018     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2009.00178.x     Document Type: Article

References (57)

1. Alexander SPH, Mathie A, Peters JA (2008). Guide to receptors and channels (GRAC), 3rd edn. 2008 revision. Br J Pharmacol 153 (Suppl. 2 S1 S209.
2. Ali H, Pearce FL (1985). Isolation and properties of cardiac and other mast cells from the rat and guinea-pig. Agents Actions 16 : 138 140. (Pubitemid 15116676)
3. Assem ESK, Schild HO (1973). Beta-adrenergic receptors concerned with the anaphylactic mechanism. Int Archs Allergy Appl Immunol 45 : 62 69.
4. 2-agonists on inflammatory cells. J Allergy Clin Immunol 104 : S10 S17.
5. 2 adrenoceptor agonist with a 24-h duration of action. J Pharmacol Exp Ther 317 : 762 770.
6. 2-agonist, provides sustained 24-h bronchodilation in asthma. Eur Respir J 29 : 871 878.
7. Benovic JL, Staniszewski C, Mayor F, Caron MG, Lefkowitz RJ (1998). β-adrenergic kinase. Activity of partial agonists for stimulation of adenylate cyclase correlates with ability to promote receptor phosphorylation. J Biol Chem 8 : 3893 3897.
8. Bingham CO, Austen KF (2000). Mast-cell responses in the development of asthma. J Allergy Clin Immunol 105 : S527 S534.
9. Bischoff SC, Dahinden CA (1992). c-kit ligand: a unique potentiator of mediator release by human lung mast cells. J Exp Med 175 : 237 244.
10. Black J (2002). The role of mast cells in the pathophysiology of asthma. N Engl J Med 346 : 1742 1743.
11. Borgland SL, Connor M, Osborne PB, Furness JB, MacDonald JC (2003). Opiod agonists have different efficacy profiles for G protein activation, rapid desensitization, and endocytosis of mu-opiod receptors. J Biol Chem 278 : 18776 18784.
12. Brightling CJ, Bradding P, Symon FA, Holgate ST, Wardlaw AJ, Pavord ID (2002). Mast-cell infiltration of airway smooth muscle in asthma. N Engl J Med 346 : 1699 1705.
13. Butchers PR, Vardey CJ, Johnson M (1991). Salmeterol: a potent and long-acting inhibitor of inflammatory mediator release from human lung. Br J Pharmacol 104 : 672 676.
14. 2-agonists in development for asthma and chronic obstructive pulmonary disease. Expert Opin Investig Drugs 14 : 775 783.
15. Chong LK, Peachell PT (1999). β-Adrenoceptor reserve in human lung: a comparison between airway smooth muscle and mast cells. Eur J Pharmacol 378 : 115 122.
16. Chong LK, Cooper E, Vardey CJ, Peachell PT (1998). Salmeterol inhibition of mediator release from human lung mast cells by β-adrenoceptor-dependent and independent mechanisms. Br J Pharmacol 123 : 1009 1015.
17. Chong LK, Chess-Williams R, Peachell PT (2002). Pharmacological characterisation of the β-adrenoceptor expressed by human lung mast cells. Eur J Pharmacol 437 : 1 7.
18. 2-adrenoceptor agonists in human lung mast cells. Br J Pharmacol 138 : 512 520.
19. Church MK, Hiroi J (1987). Inhibition of IgE-dependent histamine release from human dispersed lung mast cells by anti-allergic drugs and salbutamol. Br J Pharmacol 90 : 421 429.
20. Clark RB, Knoll BJ, Barber R (1999). Partial agonists and G protein-coupled receptor desensitization. Trends Pharmacol Sci 20 : 279 286.
21. Cockcroft DW, McParland CP, Britto SA, Swystun VA, Rutherford BC (1993). Regular inhaled salbutamol and airway responsiveness to allergen. Lancet 342 : 833 837.
22. Ennis M (1991). Current techniques of histamine determination: automated fluorometric assays. Handbook Exp Pharmacol 97 : 31 38.
23. Gilbert HS, Ornstein L (1975). Basophil counting with a new staining method using alcian blue. Blood 46 : 279 286.
24. Holgate ST, Hardy C, Robinson C, Agius RM, Howarth PH (1986). The mast cell as a primary effector cell in the pathogenesis of asthma. J Allergy Clin Immunol 77 : 274 282. (Pubitemid 16129017)
25. Holgate ST, Peters-Golden M, Panettieri RA, Henderson WR (2003). Roles of cysteinyl leukotrienes in airway inflammation, smooth muscle function, and remodeling. J Allergy Clin Immunol 111 : S18 S36.
26. Howarth PH, Durham SH, Lee TM, Kay AB, Church MK, Holgate ST (1985). Influence of albuterol, cromolyn sodium and ipratropium bromide on the airway and circulating mediator responses to allergen bronchial provocation in asthma. Am Rev Respir Dis 132 : 986 992.
27. 2-Adrenergic receptor desensitization, internalization, and phosphorylation in response to full and partial agonists. J Biol Chem 272 : 23871 23879.
28. Kenakin TP (1984). The classification of drugs and drug receptors in isolated tissues. Pharmacol Rev 36 : 165 222.
29. Ketchell RI, Jensen MW, Spina D, O'Connor BJ (2002). Dose-related effects of formoterol on airway responsiveness to adenosine 5' monophosphate and histamine. Eur Respir J 19 : 611 616.
30. Kohout TA, Lefkowitz RJ (2003). Regulation of G protein-coupled receptor kinases and arrestins during receptor desensitization. Mol Pharmacol 63 : 9 18.
31. Jokic R, Swystun VA, Davis BE, Cockcroft DW (2001). Regular inhaled salbutamol. Effect on airway responsiveness to methacholine and adenosine 5'-monophosphate and tolerance to bronchoprotection. Chest 119 : 370 375.
32. 2-adrenoceptor agonists on mast cells of rat, guinea pig, and human. Int Arch Allergy Immunol 105 : 177 180.
33. Lowman MA, Rees PH, Benyon RC, Church MK (1988). Human mast cell heterogeneity: histamine release from mast cells dispersed from skin, lung, adenoids, tonsils and colon in response to IgE-dependent and non-immunologic stimuli. J Allergy Clin Immunol 81 : 590 597.
34. Nials AT, Ball DI, Butchers PR, Coleman RA, Humbles AA, Johnson M et al. (1994). Formoterol on airway smooth muscle and human lung mast cells - a comparison with salbutamol and salmeterol. Eur J Pharmacol 251 : 127 135.
35. Nightingale JA, Rogers DF, Barnes PJ (1999). Differential effect of formoterol on adenosine monophosphate and histamine reactivity in asthma. Am J Respir Crit Care Med 159 : 1786 1790.
36. 2-agonists in asthma. N Engl J Med 327 : 1204 1208.
37. 2-agonists. Greater protection against adenosine monophosphate- than methacholine-induced bronchoconstriction in asthma. Am J Respir Crit Care Med 150 : 381 387.
38. 2-selective adrenoceptor antagonist and can be used to characterize beta-adrenoceptor populations in tissues. Life Sci 27 : 671 677.
39. Orange RP, Austen WG, Austen KF (1971). Immunological release of histamine and slow reacting substance of anaphylaxis from human lung. I. Modulation by agents influencing cellular levels of cyclic 3'5'-adenosine monophosphate. J Exp Med 134 : 136 148.
40. Pittman RN, Reynolds EE, Molinoff PB (1984). Relationship between intrinsic activities of agonists in normal and desensitized tissue and agonist-induced loss of beta-adrenergic receptors. J Pharmacol Exp Ther 230 : 614 618.
41. Proud D, Reynolds CJ, Lichtenstein LM, Kagey-Sobotka A, Togias A (1998). Intranasal salmeterol inhibits allergen-induced vascular permeability but not mast cell activation or cellular infiltration. Clin Exp Allergy 28 : 868 875.
42. Russo C, Zeng D, Prosperini G, Spicuzza L, Guarino F, Polosa R (2005). Effect of salbutamol on nasal symptoms and mast cell degranulation induced by adenosine 5' monophosphate nasal challenge. Clin Exp Allergy 35 : 1192 1196.
43. 2-agonist use in patients with asthma. Ann Intern Med 140 : 802 813.
44. Schild H (1937). Histamine release in anaphylactic shock of isolated lungs of guinea pigs. Q J Exp Physiol 26 : 165 179.
45. Schleimer RP, Schulman ES, MacGlashan DW, Peters SP, Hayes EC, Adams GK et al. (1983). Effects of dexamethasone on mediator release from human lung fragments and purified human lung mast cells. J Clin Invest 71 : 1830 1835.
46. 2- adrenoceptor-mediated responses in mast cells. Br J Pharmacol 143 : 71 80.
47. 2-adrenoceptor-mediated responses by salmeterol and formoterol. Br J Pharmacol 141 : 163 171.
48. 2-adrenoceptor agonists on changes in intracellular cyclic AMP and on cyclic AMP driven gene expression in cultured human airway smooth muscle cells. Br J Pharmacol 128 : 721 729.
49. Siraganian RP (1974). An automated continuous-flow system for the extraction and fluorometric analysis of histamine. Anal Biochem 57 : 383 394.
50. Sommerhoff CP (2001). Mast cell tryptases and airway remodeling. Am J Respir Crit Care Med 164 : S52 S58.
51. Su Y-F, Harden TK, Perkins JP (1980). Catecholamine-specific desensitization of adenylate cyclase; evidence for a multi-step process. J Biol Chem 255 : 7410 7419.
52. Swystun VA, Gordon JR, Davis B, Zhang X, Cockcroft DW (2000). Mast cell tryptase release and asthmatic responses to allergen increase with regular use of salbutamol. J Allergy Clin Immunol 106 : 57 64.
53. Taylor DA, Jensen MW, Aikman SL, Harris JG, Barnes PJ, O'Connor BJ (1997). Comparison of salmeterol and albuterol-induced bronchoprotection against adenosine monophosphate and histamine in mild asthma. Am J Respir Crit Care Med 156 : 1731 1737.
54. Undem BJ, Peachell PT, Lichtenstein LM (1988). Isoproterenol-induced inhibition of immunoglobulin E-mediated release of histamine and arachidonic acid metabolites from the human lung mast cell. J Pharmacol Exp Ther 247 : 209 217.
55. Van der Heijden PJCM, Van Amsterdam JGC, Zaagsma J (1984). Desensitization of smooth muscle and mast cell β-adrenoceptors in the airways of the guinea pig. Eur J Resp Dis 65 (Suppl. 135 128 134.
56. Waldeck B (2002). β-adrenoceptor agonists and asthma - 100 years of development. Eur J Pharmacol 445 : 1 12.
57. Williams CMM, Galli SJ (2000). The diverse potential effector and immunoregulatory roles of mast cells in allergic disease. J Allergy Clin Immunol 105 : 847 859.